Home The $10 Billion Reason That This Tiny Biotech Stock Could Soar
 

Keywords :   


The $10 Billion Reason That This Tiny Biotech Stock Could Soar

2015-02-22 17:00:08| Biotech - Topix.net

If Portola can demonstrate that betrixaban can control bleeding in hospital and post-discharge patients, it could become a big player in the $10 billion market for anticoagulants. Displacing a long-standing leader Warfarin has been used for decades by doctors to help keep blood flowing freely in heart disease and post-operative patients.

Tags: stock reason billion tiny

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 3
23.11
23.11GEN FACTORY CARVE7.7 2525.5
23.11110
23.11 ssp
23.11L
23.11
23.11 DVD-BOX6
More »